Clark Wayne
Superstar
Yeah biotechs are pretty much make or break. So much risk but so much potential reward. One failed drug trial or FDA rejection and it's overRumors coming out that it has a medical device that can compete with Intuitive Surgical's Da Vinci system and it was going to get approval from the FDA on the device soon. Then rumors started floating about Johnson & Johnson buying them. I still don't know the timing on this FDA decision though.
I like these biotech/ pharma names because of the huge moves they can make on FDA approvals or rejections of new drugs, systems, etc.
Very risky though. You get an FDA rejection of a drug you're looking at 50%+ downside. With approvals you can see the stock double or triple.
The better strategy is to probably straddle the stock with options to cut down on the risk.
A lot of these companies fail. This guy Martin Shkreli who's in the news made his name shorting these types of companies because so many fail.
Speaking of Martin Skhreli, he is the perfect example of this. Before he took over Kalobios, the stock was about 90 cents. He takes over and it jumps to a high of $45. Then after he gets arrested, it plummets to I think about $2 now and has declared bankruptcy